Koch, Gary
Mayo Clinic
From the Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN (V.E.T.); the Section of Nephrology, University of Chicago, Chicago (A.B.C.); the Institute of Physiology, University of Zurich, Zurich, Switzerland (O.D.); the Division of Nephro
Citations 1
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Torres, Vicente E. , Chapman, Arlene B., Devuyst, Olivier , Gansevoort, Ron T. , Koch, Gary G., Ouyang, John , McQuade, Robert D., Blais, Jaime D., Czerwiec, Frank S., Sergeyeva, Olga, Manunta, Paolo , Meur, Yannick Le , Rahbari-Oskoui, Frederic F. , Gale, Daniel P. , Niepen, Patricia Van der , Shirazian, Shayan , Barratt, Jonathan , Bammens, Bert , Bech, Jesper Nørgaard , Tesař, Vladimı́r , Perrone, Ronald D. , Koch, Gary, Gale, Daniel P , Torres, Vicente E , Barratt, Jonathan , Tesar, Vladimir , Rahbari-Oskoui, Frederic F , Devuyst, Olivier; https://orcid.org/0000-0003-3744-4767
New England Journal of Medicine | November 4, 2017 | Volume: 377 | Issue: 20 | Pages: 1930-1942
